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Background
The immunogenicity of adenovirus serotype 5 (Ad5) vec-
tors is suppressed by pre-existing neutralizing antibodies
(NAbs) that are directed primarily against the hexon
hypervariable regions (HVRs). We previously reported
that replacing all 7 HVRs of the Ad5 hexon protein with
those from the rare serotype Ad48 resulted in a chimeric
Ad5HVR48(1–7) vector that evaded pre-existing immu-
nity in preclinical studies.
Methods
An intermediate Ad5HVR48(1–3) vector was constructed
by replacing only the first three HVRs of Ad5 with those of
Ad48. C57/BL6 mice, either naïve or preimmunized twice
with 1010 vp of Ad5Empty, were immunized with 109 vp
of Ad5, Ad5HVR48(1–3) or Ad5HVR48(1–7) vectors
expressing SIV-Gag. Gag-specific CD8+ T cell responses
were measured by tetramer binding, ELISPOT and ICS
assays following immunization. Human and murine sera
were also assessed for neutralizing antibody responses
against Ad5, Ad5HVR48(1–3), Ad5HVR48(1–7), and
Ad48.
Results
Ad5, Ad5HVR48(1–3), and Ad5HVR48(1–7) vectors
expressing SIV-Gag proved comparably immunogenic in
mice by tetramer, ELISPOT, and ICS assays. In the pres-
ence of Ad5-specific pre-existing immunity, however, the
immunogenicity of Ad5 and Ad5HVR48(1–3) vectors was
abrogated and only Ad5HVR48(1–7) was immunogenic.
NAb titers in Ad5-vaccinated mice as well as in humans
from sub-Saharan Africa were stratified as follows: Ad5
>Ad5HVR48(1–3) > Ad5HVR48(1–7) > Ad48.
Conclusion
The serology studies indicate that a fraction of Ad5-spe-
cific NAbs are directed against HVR 1–3. However, the
Ad5HVR48(1–3) vector was unable to evade Ad5-specific
NAbs in vivo. These data indicate that HVR 4–7 contain
key Ad5-specific NAb epitopes.
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